Brain Aging and Alzheimer's Disease*-Reference-Cited by-同舟云学术

Brain Aging and Alzheimer's Disease*

Published:1978-06 Issue:4 Volume:23 Page:229-233
ISSN:0008-4824
Container-title:Canadian Psychiatric Association Journal
language:en
Short-container-title:Canadian Psychiatric Association Journal

Author:

Crapper D.R.¹,Deboni U.²

Affiliation:

1. Departments of Physiology and Medicine, University of Toronto, Toronto, Ontario.

2. Department of Physiology, University of Toronto.

Abstract

The most common cause of senile dementia appears to be a pathological process indistinguishable from that found in presenile dementia of the Alzheimer type. Consideration of the neuropathological changes suggest that this disease may involve the interaction of at least three processes: a viral-like infection, a disorder in the immune system and the neurotoxic effect of an environmental agent. The evidence in support of this hypothesis is reviewed.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/070674377802300406

Reference21 articles.

1. The Dialysis Encephalopathy Syndrome

2. SERUM PROTEINS, AMYLOID AND ALZHEIMER'S DISEASE*

3. AMYLOID PLAQUES IN THE BRAINS OF MICE INFECTED WITH SCRAPIE: MORPHOLOGICAL VARIATION AND STAINING PROPERTIES

4. Paired helical filaments of the Alzheimer type in cultured neurones

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive Enhancing Activity of Lysimachia christinae Extract on Scopolamine-induced Memory Impairment in Mice;Natural Product Sciences;2024-06-30

2. Microglia and amyloid plaque formation in Alzheimer's disease – Evidence, possible mechanisms, and future challenges;Journal of Neuroimmunology;2024-05

3. Cognitive Enhancing Activity of Fermented Aloe arborescens Extract on Scopolamine-induced Memory Impairment in Mice;Pharmacognosy Magazine;2022-12-16

4. Protective effect of fermented aloe extract on glutamate-induced cytotoxicity in HT22 cells;Animal Cells and Systems;2022-11-02

5. Potential Virus Involvement in Alzheimer’s Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination;Journal of Alzheimer's Disease Reports;2021-05-16